Grape King Bio Ltd Stock price

Equities

1707

TW0001707008

Food Processing

End-of-day quote Taiwan S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
161.5 TWD +0.94% Intraday chart for Grape King Bio Ltd +3.53% +3.53%
Sales 2024 * 11.53B 361M Sales 2025 * 12.07B 378M Capitalization 23.92B 749M
Net income 2024 * 1.6B 50.03M Net income 2025 * 1.67B 52.26M EV / Sales 2024 * 1.66 x
Net cash position 2024 * 4.74B 148M Net cash position 2025 * 4.85B 152M EV / Sales 2025 * 1.58 x
P/E ratio 2024 *
15.3 x
P/E ratio 2025 *
15 x
Employees -
Yield 2024 *
4.42%
Yield 2025 *
4.57%
Free-Float 78.59%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.94%
1 week+3.53%
Current month+4.19%
1 month+3.86%
3 months+3.86%
6 months+4.53%
Current year+3.53%
More quotes
1 week
156.00
Extreme 156
163.00
1 month
152.00
Extreme 152
163.00
Current year
151.50
Extreme 151.5
163.00
1 year
147.50
Extreme 147.5
190.00
3 years
120.00
Extreme 120
191.00
5 years
120.00
Extreme 120
234.00
10 years
120.00
Extreme 120
282.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 09-06-18
Director of Finance/CFO - 13-12-31
Chief Tech/Sci/R&D Officer 73 23-01-03
Members of the board TitleAgeSince
Director/Board Member - 21-07-14
Director/Board Member - 97-06-15
Chief Executive Officer - 09-06-18
More insiders
Date Price Change Volume
24-03-28 161.5 +0.94% 536,837
24-03-27 160 +0.95% 349,026
24-03-26 158.5 -1.55% 927,714
24-03-25 161 +2.22% 1,090,686
24-03-22 157.5 +0.96% 553,316

End-of-day quote Taiwan S.E., March 27, 2024

More quotes
Grape King Bio Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of healthcare products and beverages. The company operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The Company operates in Taiwan, mainland China and other markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
161.5 TWD
Average target price
172.8 TWD
Spread / Average Target
+6.97%
Consensus
  1. Stock
  2. Equities
  3. Stock Grape King Bio Ltd - Taiwan S.E.